Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.

According to a new study published by the European Journal of Pharmacology, and epublished by the U.S. National Institute of Health, cannabidiol (CBD) reduces airway inflammation and fibrosis in experimental allergic asthma. “Asthma remains a major public health problem and, at present, there are no effective … Continue reading Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.